Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marker Therapeutics (MRKR) Total Debt (2016 - 2023)

Historic Total Debt for Marker Therapeutics (MRKR) over the last 7 years, with Q1 2023 value amounting to $97400.0.

  • Marker Therapeutics' Total Debt changed N/A to $97400.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $97400.0, marking a year-over-year change of. This contributed to the annual value of $2.5 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Marker Therapeutics reported Total Debt of $97400.0 as of Q1 2023.
  • In the past 5 years, Marker Therapeutics' Total Debt registered a high of $8.1 million during Q2 2022, and its lowest value of $31000.0 during Q4 2019.
  • For the 3-year period, Marker Therapeutics' Total Debt averaged around $2.0 million, with its median value being $113200.0 (2019).
  • Examining YoY changes over the last 5 years, Marker Therapeutics' Total Debt showed a top increase of 62500.0% in 2019 and a maximum decrease of 5578.23% in 2019.
  • Quarter analysis of 3 years shows Marker Therapeutics' Total Debt stood at $31000.0 in 2019, then surged by 7964.52% to $2.5 million in 2022, then crashed by 96.1% to $97400.0 in 2023.
  • Its last three reported values are $97400.0 in Q1 2023, $2.5 million for Q4 2022, and $5.1 million during Q3 2022.